Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nocturnal Hemoglobinuria (PNH) Study

Paul Theisen
Patient Acquisition

Frank Burrell
Scientific Storytelling

Brenda Snow
Authentic Patient Voice

Liz Kane
Impactful Strategy

Daniel Sontupe
Market Access

Amy Giles
Increasing Engagement

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Stacey Gandler
Brand Nourishment

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Matthew Durham
Omnidynamic Marketing